Bekim Bajrami
Company: Biogen
Job title: Associate Scientific Director
Seminars:
Pioneering Novel Kinase Inhibitors: Facilitating CNS Penetration to Combat Neurodegenerative Diseases 9:00 am
Understanding the unique characteristics of BTK inhibitors and degraders to enable translatability Maintaining neuroprotective functions of compounds to limit pleiotropic off-target effects common to BTK inhibitors and degraders Prioritizing efficacy over specific targets as a benchmark for optimizing compounds within in vitro models to successfully induce neuroprotectionRead more
day: Conference Day Two